Gilead Sciences (board member)

E84182

biopharmaceutical company public company

Gilead Sciences is a major American biopharmaceutical company known for developing antiviral drugs, including treatments for HIV, hepatitis C, and other serious diseases.

Try in SPARQL Jump to: Surface forms Disambiguation Statements Elicitation Referenced by

All labels observed (4)

Label	Occurrences
Gilead Sciences	19
Gilead Sciences, Inc.	2
Gilead Sciences (board member) canonical	1
Gilead Sciences (headquarters)	1

How this entity was disambiguated

This entity first appeared as the object of triple T705758 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.

NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07

Target entity: Gilead Sciences (board member)
Context triple: [Donald Rumsfeld, employer, Gilead Sciences (board member)]

A. Biogen
Biogen is a major American biotechnology company known for developing therapies for neurological and neurodegenerative diseases.
B. Eli Lilly and Company
Eli Lilly and Company is a major American pharmaceutical corporation known for developing and manufacturing a wide range of prescription medicines, including treatments for diabetes, cancer, and mental health disorders.
C. Ionis Pharmaceuticals
Ionis Pharmaceuticals is a biotechnology company specializing in the discovery and development of RNA-targeted therapeutics using antisense technology.
D. Genentech
Genentech is a pioneering American biotechnology company known for developing groundbreaking therapies and being one of the first firms to apply genetic engineering to medicine.
E. Eisai
Eisai is a Japanese pharmaceutical company known for developing treatments in neurology and oncology, including Alzheimer’s disease therapies.
F. None of above. chosen
G. Unsure - the case is ambiguous/there is not enough information to decide.

NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07

Target entity: Gilead Sciences (board member)
Target entity description: Gilead Sciences is a major American biopharmaceutical company known for developing antiviral drugs, including treatments for HIV, hepatitis C, and other serious diseases.

A. Biogen
Biogen is a major American biotechnology company known for developing therapies for neurological and neurodegenerative diseases.
B. Eli Lilly and Company
Eli Lilly and Company is a major American pharmaceutical corporation known for developing and manufacturing a wide range of prescription medicines, including treatments for diabetes, cancer, and mental health disorders.
C. Ionis Pharmaceuticals
Ionis Pharmaceuticals is a biotechnology company specializing in the discovery and development of RNA-targeted therapeutics using antisense technology.
D. Genentech
Genentech is a pioneering American biotechnology company known for developing groundbreaking therapies and being one of the first firms to apply genetic engineering to medicine.
E. Eisai
Eisai is a Japanese pharmaceutical company known for developing treatments in neurology and oncology, including Alzheimer’s disease therapies.
F. None of above. chosen

Statements (49)

Predicate	Object
instanceOf	biopharmaceutical company ⓘ public company ⓘ
country	United States ⓘ linked to: United States of America
developed	bictegravir ⓘ emtricitabine ⓘ ledipasvir ⓘ remdesivir ⓘ sofosbuvir ⓘ tenofovir alafenamide ⓘ tenofovir disoproxil fumarate ⓘ velpatasvir ⓘ
focusesOn	COVID-19 treatment ⓘ HIV treatment ⓘ antiviral drugs ⓘ hepatitis B treatment ⓘ hepatitis C treatment ⓘ
founded	1987 ⓘ
foundedBy	John C. Martin ⓘ Michael L. Riordan ⓘ Other early co-founders and investors ⓘ Paris Panayiotopoulos ⓘ
foundedIn	California ⓘ linked to: California, United States
hasBoardOfDirectors	yes ⓘ
headquartersLocation	Foster City, California, United States ⓘ linked to: Foster City, California
industry	biotechnology ⓘ pharmaceuticals ⓘ
isMajorCompanyIn	antiviral drug development ⓘ
knownFor	HIV antiretroviral drugs ⓘ development of antiviral therapies ⓘ hepatitis C direct-acting antivirals ⓘ
listedOn	NASDAQ ⓘ
operatesIn	global market ⓘ
product	Biktarvy ⓘ Descovy ⓘ Epclusa ⓘ Harvoni ⓘ Sovaldi ⓘ Truvada ⓘ Veklury ⓘ
researchFocus	infectious diseases ⓘ inflammation ⓘ oncology ⓘ
revenueSource	prescription drugs ⓘ
specializesIn	COVID-19 therapeutics ⓘ HIV/AIDS therapeutics ⓘ inflammatory diseases ⓘ oncology ⓘ viral hepatitis therapeutics ⓘ
tickerSymbol	GILD ⓘ

How these facts were elicited